Citations (307)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (42)
Alessio Nocentini, Alessandro Bonardi, Simone Pratesi, Paola Gratteri, Carlo Dani & Claudiu T. Supuran. (2022) Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 487-501.
Read now
Read now
Ayaka Kojima, Masayuki Nadai & Miki Katoh. (2022) Species and tissue differences in regorafenib glucuronidation. Xenobiotica 52:2, pages 129-133.
Read now
Read now
Mahmoud Moqadam, Thibault Tubiana, Emmanuel E. Moutoussamy & Nathalie Reuter. (2021) Membrane models for molecular simulations of peripheral membrane proteins. Advances in Physics: X 6:1.
Read now
Read now
Julián Lozano-Castellón, Anallely López-Yerena, José Fernando Rinaldi de Alvarenga, Jaume Romero del Castillo-Alba, Anna Vallverdú-Queralt, Elvira Escribano-Ferrer & Rosa M. Lamuela-Raventós. (2020) Health-promoting properties of oleocanthal and oleacein: Two secoiridoids from extra-virgin olive oil. Critical Reviews in Food Science and Nutrition 60:15, pages 2532-2548.
Read now
Read now
Molly Lin, Justin Ly, Ryan Takahashi, John Chen, Alan Deese, Sarah J. Robinson, Aleksandr Kolesnikov, Susan Wong, Xiaojing Wang & Jae H. Chang. (2018) Characterizing the in vitro species differences in N-glucuronidation of a potent pan-PIM inhibitor GNE-924 containing a 3,5-substituted 6-azaindazole. Xenobiotica 48:10, pages 1021-1027.
Read now
Read now
Heta Shah, Manish Patel & Neeta Shrivastava. (2017) Gene expression study of phase I and II metabolizing enzymes in RPTEC/TERT1 cell line: application in in vitro nephrotoxicity prediction. Xenobiotica 47:10, pages 837-843.
Read now
Read now
Atsunori Miyata, Masatoshi Hasegawa, Kenji Hachiuma, Haruyuki Mori, Nobuko Horiuchi, Akiko Mizuno-Yasuhira, Yukihiro Chino, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa, Yasuhiro Nakai & Jun-ichi Yamaguchi. (2017) Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, in humans. Xenobiotica 47:4, pages 332-345.
Read now
Read now
Melanie A. Ladd, Patrick N. Fitzsimmons & John W. Nichols. (2016) Optimization of a UDP-glucuronosyltransferase assay for trout liver S9 fractions: activity enhancement by alamethicin, a pore-forming peptide. Xenobiotica 46:12, pages 1066-1075.
Read now
Read now
Cui Gao, Rong Shi, Tianming Wang, Hongsheng Tan, Hongxi Xu & Yueming Ma. (2015) Interaction between oblongifolin C and UDP-glucuronosyltransferase isoforms in human liver and intestine microsomes. Xenobiotica 45:7, pages 578-585.
Read now
Read now
Zoe Riches & Abby C Collier. (2015) Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases. Expert Opinion on Drug Metabolism & Toxicology 11:6, pages 949-965.
Read now
Read now
Jolantha Beyerle, Eva Frei, Marie Stiborova, Nina Habermann & Cornelia M. Ulrich. (2015) Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer. Drug Metabolism Reviews 47:2, pages 199-221.
Read now
Read now
Yu-Shuai Peng, Bin Liu, Ru-Feng Wang, Qi-Tao Zhao, Wei Xu & Xiu-Wei Yang. (2015) Hepatic metabolism: a key component of herbal drugs research. Journal of Asian Natural Products Research 17:1, pages 89-106.
Read now
Read now
Bao-Li Mi, Qi Sun, Yan-Qing Qu, Xiao-Xu Gao, Zhen-Wen Yu, Guang-Bo Ge, Shan-Shan Cai, Jie Zhang, Yan-Chao Zheng & Zhen-Qiu Zhang. (2014) Glucuronidation of aurantio-obtusin: identification of human UDP-glucuronosyltransferases and species differences. Xenobiotica 44:8, pages 716-721.
Read now
Read now
Christopher R. Gibson, Ping Lu, Cheri Maciolek, Christen Wudarski, Zoe Barter, Karen Rowland-Yeo, Mark Stroh, Eseng Lai & Deborah A. Nicoll-Griffith. (2013) Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans. Xenobiotica 43:12, pages 1027-1036.
Read now
Read now
Tuomas Rahikainen, Merja R. Häkkinen, Moshe Finel, Markku Pasanen & Risto O. Juvonen. (2013) A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomes. Xenobiotica 43:10, pages 853-861.
Read now
Read now
Satya Prakash Tripathi, Anuseema Bhadauriya, Abhijeet Patil & Abhay T. Sangamwar. (2013) Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights. Drug Metabolism Reviews 45:2, pages 231-252.
Read now
Read now
Kristi L Helke & Marvin Michael Swindle. (2013) Animal models of toxicology testing: the role of pigs. Expert Opinion on Drug Metabolism & Toxicology 9:2, pages 127-139.
Read now
Read now
Jillissa C. Molnari & Alan L. Myers. (2012) Carbonyl reduction of bupropion in human liver. Xenobiotica 42:6, pages 550-561.
Read now
Read now
Hiroshi Komura & Masahiro Iwaki. (2011) In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences. Drug Metabolism Reviews 43:4, pages 476-498.
Read now
Read now
Yazhi Wang, Heisio Ao, Zhengming Qian & Ying Zheng. (2011) Intestinal transport of scutellarein and scutellarin and first-pass metabolism by UDP-glucuronosyltransferase-mediated glucuronidation of scutellarein and hydrolysis of scutellarin. Xenobiotica 41:7, pages 538-548.
Read now
Read now
Tingting Li, Yi Zheng, Feifei Fu, Hui Ji, Xijing Chen, Ying Zhao, Di Zhao, Ning Li & Lingli Zhang. (2011) Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs. Xenobiotica 41:7, pages 530-537.
Read now
Read now
John O. Miners, Peter I. Mackenzie & Kathleen M. Knights. (2010) The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metabolism Reviews 42:1, pages 196-208.
Read now
Read now
Yin Cheong Wong, Li Zhang, Ge Lin & Zhong Zuo. (2009) Structure–activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases. Expert Opinion on Drug Metabolism & Toxicology 5:11, pages 1399-1419.
Read now
Read now
Margherita Strolin Benedetti, Rhys Whomsley, Italo Poggesi, Willi Cawello, François-Xavier Mathy, Marie-Laure Delporte, Peggy Papeleu & Jean-Baptiste Watelet. (2009) Drug metabolism and pharmacokinetics. Drug Metabolism Reviews 41:3, pages 344-390.
Read now
Read now
Jenny J Schulze, Anders Rane & Lena Ekström. (2009) Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse. Expert Opinion on Drug Metabolism & Toxicology 5:7, pages 731-744.
Read now
Read now
Carlos A Zarate$suffix/text()$suffix/text() & Husseini K Manji. (2008) Riluzole in psychiatry: a systematic review of the literature. Expert Opinion on Drug Metabolism & Toxicology 4:9, pages 1223-1234.
Read now
Read now
Anne T Nies, Matthias Schwab & Dietrich Keppler. (2008) Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. Expert Opinion on Drug Metabolism & Toxicology 4:5, pages 545-568.
Read now
Read now
M. Mukoyoshi, S. Nishimura, S. Hoshide, S. Umeda, M. Kanou, K. Taniguchi & H. Muroga. (2008) drug–drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition. Xenobiotica 38:5, pages 496-510.
Read now
Read now
Young-Mi Ah, Young-Mi Kim, Min-Jung Kim, Young Hee Choi, Kyoung-Ho Park, In-Ja Son & Sang Geon Kim. (2008) Drug-induced Hyperbilirubinemia and the Clinical Influencing Factors. Drug Metabolism Reviews 40:4, pages 511-537.
Read now
Read now
Mary F Paine & Nicholas H Oberlies. (2007) Clinical relevance of the small intestine as an organ of drug elimination: drug–fruit juice interactions. Expert Opinion on Drug Metabolism & Toxicology 3:1, pages 67-80.
Read now
Read now
N. Kanayama, C. Kanari, Y. Masuda, S. Ohmori & T. Ooie. (2007) Drug–drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. Xenobiotica 37:2, pages 139-154.
Read now
Read now
C. W. Locuson & T. S. Tracy. (2007) Comparative modelling of the human UDP-glucuronosyltransferases: Insights into structure and mechanism. Xenobiotica 37:2, pages 155-168.
Read now
Read now
Reinier M van Hest, Dennis A Hesselink, Arnold G Vulto, Ron AA Mathot & Teun van Gelder. (2006) Individualisation of mycophenolate mofetil dose in renal transplant recipients. Expert Opinion on Pharmacotherapy 7:4, pages 361-376.
Read now
Read now
Giulia Corona, Xenofon Tzounis, M. Assunta DessÌ, Monica Deiana, Edward S. Debnam, Francesco Visioli & Jeremy P. E. Spencer. (2006) The fate of olive oil polyphenols in the gastrointestinal tract: Implications of gastric and colonic microflora-dependent biotransformation. Free Radical Research 40:6, pages 647-658.
Read now
Read now
H. Wong, H. Wong, J. E. Grace Jr, M. R. Wright, H. Wong, J. E. Grace Jr, M. R. Wright, M. R. Browning, S. J. Grossman, S. A. Bai, H. Wong, J. E. Grace Jr, M. R. Wright, M. R. Browning, S. J. Grossman, S. A. Bai, D. D. Christ, H. Wong, J. E. Grace Jr, M. R. Wright, M. R. Browning, S. J. Grossman, S. A. Bai & D. D. Christ. (2006) Glucuronidation in the chimpanzee (): Studies with acetaminophen, oestradiol and morphine. Xenobiotica 36:12, pages 1178-1190.
Read now
Read now
H. M. Jones, G. Nicholls & J. B. Houston. (2005) Impact of end-product inhibition on the determination of in vitro metabolic clearance. Xenobiotica 35:5, pages 439-454.
Read now
Read now
Balram Chowbay, Shufeng Zhou & Edmund J. D. Lee. (2005) An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in Singapore. Drug Metabolism Reviews 37:2, pages 327-378.
Read now
Read now
Shufeng Zhou, Eli Chan, Wei Duan, Min Huang & Yu-Zong Chen. (2005) Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance. Drug Metabolism Reviews 37:1, pages 41-213.
Read now
Read now
Raymond A. Kemper & Diane L. Nabb. (2005) In Vitro Studies in Microsomes from Rat and Human Liver, Kidney, and Intestine Suggest That Perfluorooctanoic Acid Is Not a Substrate for Microsomal UDP-Glucuronosyltransferases. Drug and Chemical Toxicology 28:3, pages 281-287.
Read now
Read now
A. K. Fröhlich, U. Girreser & B Clement. (2005) Metabolism of benzamidoxime (N-hydroxyamidine) in human hepatocytes and role of UDP-glucuronosyltransferases. Xenobiotica 35:1, pages 17-25.
Read now
Read now
A. Treiber, P. L. M. Van Giersbergen & J. Dingemanse. (2003) In vivo and in vitro disposition profile of tezosentan, an intravenous dual endothelin receptor antagonist, in humans. Xenobiotica 33:4, pages 399-414.
Read now
Read now
K. Takemoto, H. Yamazaki, Y. Tanaka, M. Nakajima & T. Yokoi. (2003) Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes. Xenobiotica 33:1, pages 43-55.
Read now
Read now
Articles from other publishers (265)
Ngoc Tran, William E. Fantegrossi, Keith R. McCain, Xinwen Wang & Ryoichi Fujiwara. (2023) Identification of Cytochrome P450 Enzymes Responsible for Oxidative Metabolism of Synthetic Cannabinoid (1-Hexyl-1H-Indol-3-yl)-1-naphthalenyl-methanone (JWH-019). Catalysts 13:6, pages 1008.
Crossref
Crossref
Ankur Sood, Atul Dev, Sabya Sachi Das, Hyeon Jin Kim, Anuj Kumar, Vijay Kumar Thakur & Sung Soo Han. (2023) Curcumin-loaded alginate hydrogels for cancer therapy and wound healing applications: A review. International Journal of Biological Macromolecules 232, pages 123283.
Crossref
Crossref
Yi-fei He, Yin Liu, Jing-hua Yu, Huan Cheng, Abdullajon Odilov, Fei-pu Yang, Guang-hui Tian, Xiu-mei Yao, Hua-qing Duan, Cheng-yin Yu, Chen Yu, Yan-mei Liu, Gang-yi Liu, Jing-shan Shen, Zhen Wang & Xing-xing Diao. (2022) Pharmacokinetics, mass balance, and metabolism of [14C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension. Acta Pharmacologica Sinica 44:1, pages 221-233.
Crossref
Crossref
CARL DAVIS. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
527
552
.
Selina Hemmer, Lea Wagmann, Benedikt Pulver, Folker Westphal & Markus R. Meyer. (2022) In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MS. Metabolites 12:12, pages 1209.
Crossref
Crossref
Rentong Hu, Weerachai Chantana, Pornsiri Pitchakarn, Subhawat Subhawa, Bhanumas Chantarasuwan, Piya Temviriyanukul & Teera Chewonarin. (2022) Ficus dubia latex extract prevent DMH-induced rat early colorectal carcinogenesis through the regulation of xenobiotic metabolism, inflammation, cell proliferation and apoptosis. Scientific Reports 12:1.
Crossref
Crossref
Drago Bešlo, Gloria Došlić, Dejan Agić, Vesna Rastija, Marcela Šperanda, Vesna Gantner & Bono Lučić. (2022) Polyphenols in Ruminant Nutrition and Their Effects on Reproduction. Antioxidants 11:5, pages 970.
Crossref
Crossref
Sheila Annie Peters. 2021. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations
263
292
.
Sheila Annie Peters. 2021. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations
129
167
.
Qi-Hang Zhou, Wei-Wei Qin, Moshe Finel, Qing-Qing He, Dong-Zhu Tu, Chao-Ran Wang & Guang-Bo Ge. (2021) A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors. International Journal of Biological Macromolecules 180, pages 252-261.
Crossref
Crossref
Ya-Di Zhu, Xiao-Qing Guan, Jing Chen, Sheng Peng, Moshe Finel, Ying-Yuan Zhao, Rui-Min Wang, Hui-Chang Bi, Ming Lei, Dan-Dan Wang & Guang-Bo Ge. (2021) Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ. Frontiers in Pharmacology 11.
Crossref
Crossref
John O. Miners, Andrew Rowland, Jonathan J. Novak, Kimberly Lapham & Theunis C. Goosen. (2021) Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping. Pharmacology & Therapeutics 218, pages 107689.
Crossref
Crossref
Jin Zhou, Upendra A. Argikar & John O. Miners. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
301
338
.
E. E. J. Kasteel, K. Darney, N. I. Kramer, J. L. C. M. Dorne & L. S. Lautz. (2020) Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors. Archives of Toxicology 94:8, pages 2637-2661.
Crossref
Crossref
Huan Liu, Zhaolin Sun, Xiaoting Tian, Qin Feng, Ziqiong Guo, Shuoji Chen, Hao Yin, Yangyang Wang, Zhou Xu, Like Xie, Pei Hu & Chenggang Huang. (2020)
Systematic investigation on the chemical basis of anti‐NAFLD Qushi Huayu Fang. Part 1: A study of metabolic profiles
in vivo
and
in vitro
by high‐performance liquid chromatography–quadrupole time‐of‐flight mass spectrometry
. Biomedical Chromatography 34:5.
Crossref
Crossref
Hui Zhi, Yuan Yuan, Chunzhen Zhang, Yiguo Jiang, Hongjian Zhang, Cheng Wang & Jianqing Ruan. (2020) Importance of OATP1B1 and 1B3 in the Liver Uptake of Luteolin and Its Consequent Glucuronidation Metabolites. Journal of Agricultural and Food Chemistry 68:7, pages 2063-2070.
Crossref
Crossref
Anima Ghosal. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters
237
271
.
Guy Montay, Jochen Maas & Roland Wesch. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1019
1046
.
Andrés Sauvêtre, Peter Eichhorn & Sandra Pérez. 2021. Interaction and Fate of Pharmaceuticals in Soil-Crop Systems. Interaction and Fate of Pharmaceuticals in Soil-Crop Systems
221
264
.
Lesa A. Thompson, Yoshinori Ikenaka, Wageh Sobhy Darwish, Shouta M.M. Nakayama, Hazuki Mizukawa & Mayumi Ishizuka. (2019) Effects of the organochlorine p,p’-DDT on MCF-7 cells: Investigating metabolic and immune modulatory transcriptomic changes. Environmental Toxicology and Pharmacology 72, pages 103249.
Crossref
Crossref
Theodoros Papathanasiou, Anders Deichmann Springborg, Kenneth Thermann Kongstad, Dan Staerk, Kirsten Møller, Bradley Kenneth Taylor, Trine Meldgaard Lund & Mads Utke Werner. (2019) High-dose naloxone, an experimental tool uncovering latent sensitisation: pharmacokinetics in humans. British Journal of Anaesthesia 123:2, pages e204-e214.
Crossref
Crossref
Keumhan Noh & K. Sandy Pang. (2019) Theoretical consideration of the properties of intestinal flow models on route‐dependent drug removal: Segregated Flow (SFM) vs. Traditional (TM). Biopharmaceutics & Drug Disposition 40:5-6, pages 195-213.
Crossref
Crossref
Xin-Yu Liu, Xia Lv, Ping Wang, Chun-Zhi Ai, Qi-Hang Zhou, Moshe Finel, Bin Fan, Yun-Feng Cao, Hui Tang & Guang-Bo Ge. (2019) Inhibition of UGT1A1 by natural and synthetic flavonoids. International Journal of Biological Macromolecules 126, pages 653-661.
Crossref
Crossref
Mark BellDavid Foley, Claire NaylorGavin WoodColin RobinsonJennifer RileyOla EpemoluLucy Ellis, Paul ScullionYoko ShishikuraMaria Osuna-CabelloLiam FergusonErika PintoDaniel FletcherElad KatzW. H. Irwin McLeanPaul Wyatt, Kevin D Read & Andrew Woodland. (2019) Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1). ACS Medicinal Chemistry Letters 10:3, pages 341-347.
Crossref
Crossref
Takaya Kutsukake, Yoichi Furukawa, Kyoko Ondo, Saki Gotoh, Tatsuki Fukami & Miki Nakajima. (2019) Quantitative Analysis of UDP-Glucuronosyltransferase Ugt1a and Ugt2b mRNA Expression in the Rat Liver and Small Intestine: Sex and Strain Differences. Drug Metabolism and Disposition 47:1, pages 38-44.
Crossref
Crossref
Xia Lv, Jian‐Bin Zhang, Jie Hou, Tong‐Yi Dou, Guang‐Bo Ge, Wen‐Zhong Hu & Ling Yang. (2018) Chemical Probes for Human UDP‐Glucuronosyltransferases: A Comprehensive Review. Biotechnology Journal 14:1.
Crossref
Crossref
Kimberly Lapham, Jian Lin, Jonathan Novak, Christine Orozco, Mark Niosi, Li Di, Theunis C. Goosen, Sangwoo Ryu, Keith Riccardi, Heather Eng, Kimberly O. Cameron & Amit S. Kalgutkar. (2018)
6-Chloro-5-[4-(1-Hydroxycyclobutyl)Phenyl]-1
H
-Indole-3-Carboxylic Acid is a Highly Selective Substrate for Glucuronidation by UGT1A1, Relative to
β
-Estradiol
. Drug Metabolism and Disposition 46:12, pages 1836-1846.
Crossref
Crossref
Lu-yang XuZheng JiaoFei-yan LiuXiao-yan QiuLi Ji & Ming Zhang. (2018) Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus. Therapeutic Drug Monitoring 40:5, pages 572-580.
Crossref
Crossref
Tim F. Ryder, Matthew F. Calabrese, Gregory S. Walker, Kimberly O. Cameron, Allan R. Reyes, Kris A. Borzilleri, Jake Delmore, Russell Miller, Ravi G. Kurumbail, Jessica Ward, Daniel W. Kung, Janice A. Brown, David J. Edmonds, Heather Eng, Angela C. Wolford & Amit S. Kalgutkar. (2018)
Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1
H
-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK)
. Journal of Medicinal Chemistry 61:16, pages 7273-7288.
Crossref
Crossref
Yi Rong, Zhiyun Meng, Jian Li, Xiaoxia Zhu, Hui Gan, Ruolan Gu, Zhuona Wu, Wenzhong Sun, Taoyun Liu, Ying Zheng, Mingji Jin, Jian Peng, Xinyu Wang & Guifang Dou. (2018) Application of ultra high-performance liquid chromatography tandem mass spectrometry to investigate the regioselective glucuronidation of icaritin in vitro. Journal of Pharmaceutical and Biomedical Analysis 154, pages 444-453.
Crossref
Crossref
Ryoichi Fujiwara, Emiko Yoda & Robert H. Tukey. (2018) Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans. Drug Metabolism and Pharmacokinetics 33:1, pages 9-16.
Crossref
Crossref
K.K. Wolf & M.F. Paine. 2018. Comprehensive Toxicology. Comprehensive Toxicology
74
98
.
Nicolas Hohmann. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
341
364
.
Guy Montay, Jochen Maas & Roland Wesch. 2019. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
28
.
Aktarul Islam Siddique, Vijay Mani, Senbagarani Renganathan, Rajagopal Ayyanar, Ananthi Nagappan & Nalini Namasivayam. (2017) Asiatic acid abridges pre-neoplastic lesions, inflammation, cell proliferation and induces apoptosis in a rat model of colon carcinogenesis. Chemico-Biological Interactions 278, pages 197-211.
Crossref
Crossref
Lingyi Huang, Dejan Nikolic & Richard B. van Breemen. (2017) Hepatic metabolism of licochalcone A, a potential chemopreventive chalcone from licorice (Glycyrrhiza inflata), determined using liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry 409:30, pages 6937-6948.
Crossref
Crossref
Pierre-André Billat, Emilie Roger, Sébastien Faure & Frédéric Lagarce. (2017) Models for drug absorption from the small intestine: where are we and where are we going?. Drug Discovery Today 22:5, pages 761-775.
Crossref
Crossref
K. Sandy Pang, Qi Joy Yang & Keumhan Noh. (2017) Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first‐pass removal with PBPK modeling. Biopharmaceutics & Drug Disposition 38:3, pages 231-250.
Crossref
Crossref
C Emoto, T Fukuda, TN Johnson, S Neuhoff, S Sadhasivam & AA Vinks. (2016) Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter. CPT: Pharmacometrics & Systems Pharmacology 6:2, pages 110-119.
Crossref
Crossref
L. Xing & J. Mathias. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
408
430
.
Brian F. Kiesel, Robert A. Parise, Jianxia Guo, Donna M. Huryn, Paul A. Johnston, Raffaele Colombo, Malabika Sen, Jennifer R. Grandis, Jan H. Beumer & Julie L. Eiseman. (2016) Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation. Cancer Chemotherapy and Pharmacology 78:6, pages 1225-1235.
Crossref
Crossref
Malgorzata Szultka-Mlynska & Boguslaw Buszewski. (2016) Study of in-vitro metabolism of selected antibiotic drugs in human liver microsomes by liquid chromatography coupled with tandem mass spectrometry. Analytical and Bioanalytical Chemistry 408:29, pages 8273-8287.
Crossref
Crossref
Qingping Wang & Meng Li. 2016. Drug Delivery. Drug Delivery
164
185
.
Liang Li, Xue-juan Huang, Jian-long Peng, Ming-yue Zheng, Da-fang Zhong, Chao-feng Zhang & Xiao-yan Chen. (2016) Wedelolactone metabolism in rats through regioselective glucuronidation catalyzed by uridine diphosphate-glucuronosyltransferases 1As (UGT1As). Phytomedicine 23:4, pages 340-349.
Crossref
Crossref
Nicolas Hohmann. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
32
.
Khalid O Alfarouk, Christian-Martin Stock, Sophie Taylor, Megan Walsh, Abdel Khalig Muddathir, Daniel Verduzco, Adil H H Bashir, Osama Y Mohammed, Gamal O Elhassan, Salvador Harguindey, Stephan J Reshkin, Muntaser E Ibrahim & Cyril Rauch. (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell International 15:1.
Crossref
Crossref
M. C. Benton, R. A. Lea, D. Macartney-Coxson, C. Bellis, M. A. Carless, J. E. Curran, M. Hanna, D. Eccles, G. K. Chambers, J. Blangero & L. R. Griffiths. (2015) Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate. BMC Genetics 16:1.
Crossref
Crossref
April P. Neal-Kluever, Allan B. Bailey & Karen R. Hatwell. (2015) Safety assessment for octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate (CAS Reg. No. 2082-79-3) from use in food contact applications. Food and Chemical Toxicology 86, pages 176-190.
Crossref
Crossref
Sivaranjani Arivalagan, Nisha Susan Thomas, Balaji Chandrasekaran, Vijay Mani, Aktarul Islam Siddique, Thayalan Kuppsamy & Nalini Namasivayam. (2015) Combined therapeutic efficacy of carvacrol and X-radiation against 1,2-dimethyl hydrazine-induced experimental rat colon carcinogenesis. Molecular and Cellular Biochemistry 410:1-2, pages 37-54.
Crossref
Crossref
J. Matthew Hutzler & Michael A. Zientek. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
79
130
.
Kristi Helke. 2015. Swine in the Laboratory. Swine in the Laboratory
419
442
.
Si-Cheng Liang, Guang-Bo Ge, Yang-Liu Xia, Jiang-Wei Zhang, Xiao-Yi Qi, Cai-Xia Tu & Ling Yang. (2015) In Vitro Evaluation of the Effect of 7-Methyl Substitution on Glucuronidation of Daphnetin: Metabolic Stability, Isoform Selectivity, and Bioactivity Analysis. Journal of Pharmaceutical Sciences 104:10, pages 3557-3564.
Crossref
Crossref
. (2015) Scientific Opinion on the risks for human health related to the presence of tetrahydrocannabinol (THC) in milk and other food of animal origin. EFSA Journal 13:6.
Crossref
Crossref
Christina Ly, Julien Yockell-Lelièvre, Zachary M. Ferraro, John T. Arnason, Jonathan Ferrier & Andrée Gruslin. (2015) The effects of dietary polyphenols on reproductive health and early development†. Human Reproduction Update 21:2, pages 228-248.
Crossref
Crossref
Mehdi Boroujerdi. 2015. Pharmacokinetics and Toxicokinetics. Pharmacokinetics and Toxicokinetics
217
266
.
Shingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi & Miki Nakajima. (2015) A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metabolism and Pharmacokinetics 30:1, pages 30-51.
Crossref
Crossref
Rosa Maria Paragliola, Alessandro Prete, Peter W Kaplan, Salvatore Maria Corsello & Roberto Salvatori. (2015) Treatment of hypopituitarism in patients receiving antiepileptic drugs. The Lancet Diabetes & Endocrinology 3:2, pages 132-140.
Crossref
Crossref
Michael A. Zientek & Kuresh Youdim. (2015) Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes. Drug Metabolism and Disposition 43:1, pages 163-181.
Crossref
Crossref
Bernard Testa & Bernd Clement. 2015. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry
561
584
.
Richard J. Auchus. 2015. Knobil and Neill's Physiology of Reproduction. Knobil and Neill's Physiology of Reproduction
295
312
.
Barbara A. Wetmore, Brittany Allen, Harvey J. ClewellIIIIII, Timothy Parker, John F. Wambaugh, Lisa M. Almond, Mark A. Sochaski & Russell S. Thomas. (2014) Incorporating Population Variability and Susceptible Subpopulations into Dosimetry for High-Throughput Toxicity Testing. Toxicological Sciences 142:1, pages 210-224.
Crossref
Crossref
Jian-Qing Ruan & Ru Yan. (2014) Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases. Chemico-Biological Interactions 220, pages 231-240.
Crossref
Crossref
Karen Larsen, Roberto Najle, Adrián Lifschitz, María L. Maté, Carlos Lanusse & Guillermo L. Virkel. (2014) Effects of Sublethal Exposure to a Glyphosate-Based Herbicide Formulation on Metabolic Activities of Different Xenobiotic-Metabolizing Enzymes in Rats. International Journal of Toxicology 33:4, pages 307-318.
Crossref
Crossref
Yuto Hiura, Hideo Satsu, Mika Hamada & Makoto Shimizu. (2014)
Analysis of flavonoids regulating the expression of UGT1A1
via
xenobiotic receptors in intestinal epithelial cells
. BioFactors 40:3, pages 336-345.
Crossref
Crossref
Haojing Song, Jin Wang, Rui Zhang, Xiaoyan Liu, Guiyan Yuan, Chunmin Wei, Benjie Wang & Ruichen Guo. (2014)
Identification and characterization of human UDP-glucuronosyltransferases responsible for the
in vitro
glucuronidation of bergenin
. Biomedical Chromatography 28:3, pages 348-353.
Crossref
Crossref
Rajamanickam Vinothkumar, Rajenderan Vinoth Kumar, Mani Sudha, Periyaswamy Viswanathan, Thangavel Balasubramanian & Namasivayam Nalini. (2014) Modulatory effect of troxerutin on biotransforming enzymes and preneoplasic lesions induced by 1,2-dimethylhydrazine in rat colon carcinogenesis. Experimental and Molecular Pathology 96:1, pages 15-26.
Crossref
Crossref
Nan Hu, Mei Mei, Jianqing Ruan, Wenjin Wu, Yitao Wang & Ru Yan. (2014) Regioselective Glucuronidation of Oxyresveratrol, a Natural Hydroxystilbene, by Human Liver and Intestinal Microsomes and Recombinant UGTs. Drug Metabolism and Pharmacokinetics 29:3, pages 229-236.
Crossref
Crossref
Michal Heger, Rowan F. van Golen, Mans Broekgaarden & Martin C. Michel. (2013) The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer. Pharmacological Reviews 66:1, pages 222-307.
Crossref
Crossref
Piper Reid Hunt, Zachary Keltner, Xiugong Gao, Steven J. Oldenburg, Priyanka Bushana, Nicholas Olejnik & Robert L. Sprando. (2014) Bioactivity of nanosilver in Caenorhabditis elegans : Effects of size, coat, and shape. Toxicology Reports 1, pages 923-944.
Crossref
Crossref
B.S. Raccor, A.M. Teitelbaum, J.C. Dinh & R.A. Totah. 2014. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Jin Zhou & John O. Miners. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
203
228
.
Michael H. Court. 2014. Optimization in Drug Discovery. Optimization in Drug Discovery
117
136
.
Kevin J. Coe & Tatiana Koudriakova. 2014. Optimization in Drug Discovery. Optimization in Drug Discovery
87
99
.
R. Vinothkumar, M. Sudha, P. Viswanathan, J. Kabalimoorthy, T. Balasubramanian & N. Nalini. (2013)
Modulating effect of
d
-carvone on 1,2-dimethylhydrazine-induced pre-neoplastic lesions, oxidative stress and biotransforming enzymes, in an experimental model of rat colon carcinogenesis
. Cell Proliferation 46:6, pages 705-720.
Crossref
Crossref
Sirkku E. Jäntti, Minna Hartonen, Mika Hilvo, Heli Nygren, Tuulia Hyötyläinen, Raimo A. Ketola & Risto Kostiainen. (2013) Steroid and steroid glucuronide profiles in urine during pregnancy determined by liquid chromatography–electrospray ionization-tandem mass spectrometry. Analytica Chimica Acta 802, pages 56-66.
Crossref
Crossref
Ayako Shibuya, Tomoo Itoh, Robert H. Tukey & Ryoichi Fujiwara. (2013) Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia. Scientific Reports 3:1.
Crossref
Crossref
Katrin Wlcek, Fabienne Koller, Peter Ferenci & Bruno Stieger. (2013) Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin. Drug Metabolism and Disposition 41:8, pages 1522-1528.
Crossref
Crossref
Katalin Révész, Blanka Tóth, Adam G. Staines, Michael W. H. Coughtrie, József Mandl & Miklós Csala. (2012) Luminal accumulation of newly synthesized morphine‐3‐glucuronide in rat liver microsomal vesicles. BioFactors 39:3, pages 271-278.
Crossref
Crossref
Katherine L. Gill, Michael Gertz, J. Brian Houston & Aleksandra Galetin. (2013) Application of a Physiologically Based Pharmacokinetic Model to Assess Propofol Hepatic and Renal Glucuronidation in Isolation: Utility of In Vitro and In Vivo Data. Drug Metabolism and Disposition 41:4, pages 744-753.
Crossref
Crossref
Jr-Ting Lee, Li-Heng Pao, Cheng-Huei Hsiong, Pei-Wei Huang, Tung-Yuan Shih & Oliver Yoa-Pu Hu. (2013) Validated liquid chromatography–tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases. Talanta 106, pages 220-228.
Crossref
Crossref
Mélanie Rouleau, Pierre Collin, Judith Bellemare, Mario Harvey & Chantal Guillemette. (2013) Protein–protein interactions between the bilirubin-conjugating UDPglucuronosyltransferase UGT1A1 and its shorter isoform 2 regulatory partner derived from alternative splicing. Biochemical Journal 450:1, pages 107-114.
Crossref
Crossref
. 2013. Canine and Feline Gastroenterology. Canine and Feline Gastroenterology
177
204
.
Peter Eichhorn. 2013. Analysis, Removal, Effects and Risk of Pharmaceuticals in the Water Cycle - Occurrence and Transformation in the Environment. Analysis, Removal, Effects and Risk of Pharmaceuticals in the Water Cycle - Occurrence and Transformation in the Environment
1
36
.
Jochen Maas, Roland Wesch & Dietmar Weitz. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1095
1123
.
Douglas K. Spracklin, Amit S. Kalgutkar & Angus N. R. Nedderman. 2014. Reducing Drug Attrition. Reducing Drug Attrition
97
137
.
Amit S. Kalgutkar & Antonia F. Stepan. 2012. Analogue‐Based Drug Discovery III. Analogue‐Based Drug Discovery III
37
75
.
Adam S. Darwich, Kathryn Henderson, Angela Burgin, Nicola Ward, Janet Whittam, Basil J. Ammori, Darren M. Ashcroft & Amin Rostami‐Hodjegan. (2012) Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes. British Journal of Clinical Pharmacology 74:5, pages 774-787.
Crossref
Crossref
Christina S. Won, Nicholas H. Oberlies & Mary F. Paine. (2012) Mechanisms underlying food–drug interactions: Inhibition of intestinal metabolism and transport. Pharmacology & Therapeutics 136:2, pages 186-201.
Crossref
Crossref
Alexander V. LyubimovPeter L. Bullock & Olga V. Trubetskoy. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
26
.
Ana Gomes, Diana Couto, Andreia Alves, Irene Dias, Marisa Freitas, Graça Porto, José Alberto Duarte & Eduarda Fernandes. (2012) Trihydroxyflavones with antioxidant and anti-inflammatory efficacy. BioFactors 38:5, pages 378-386.
Crossref
Crossref
Upendra A. Argikar. (2012) Unusual Glucuronides. Drug Metabolism and Disposition 40:7, pages 1239-1251.
Crossref
Crossref
Adam S Darwich, Devendra Pade, Basil J Ammori, Masoud Jamei, Darren M Ashcroft & Amin Rostami-Hodjegan. (2012) A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. Journal of Pharmacy and Pharmacology 64:7, pages 1008-1024.
Crossref
Crossref
Robert L. Walsky, Jonathan N. Bauman, Karine Bourcier, Georgina Giddens, Kimberly Lapham, Andre Negahban, Tim F. Ryder, R. Scott Obach, Ruth Hyland & Theunis C. Goosen. (2012) Optimized Assays for Human UDP-Glucuronosyltransferase (UGT) Activities: Altered Alamethicin Concentration and Utility to Screen for UGT Inhibitors. Drug Metabolism and Disposition 40:5, pages 1051-1065.
Crossref
Crossref
Chun Li & Nataraj Kalyanaraman. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
189
212
.
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
111
158
.
Katherine L. Gill, J. Brian Houston & Aleksandra Galetin. (2012) Characterization of In Vitro Glucuronidation Clearance of a Range of Drugs in Human Kidney Microsomes: Comparison with Liver and Intestinal Glucuronidation and Impact of Albumin. Drug Metabolism and Disposition 40:4, pages 825-835.
Crossref
Crossref
J. Debora van der Merwe, Elizabeth Joubert, Marena Manley, Dalene de Beer, Christiaan J. Malherbe & Wentzel C.A. Gelderblom. (2012) Mangiferin glucuronidation: Important hepatic modulation of antioxidant activity. Food and Chemical Toxicology 50:3-4, pages 808-815.
Crossref
Crossref
Kalipatnapu Rao. 2012. Forensic Toxicology. Forensic Toxicology
169
174
.
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
161
181
.
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
43
88
.
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
273
298
.
Toshifumi Shiraga, Kanako Yajima, Kenta Suzuki, Katsuhiro Suzuki, Tadashi Hashimoto, Takafumi Iwatsubo, Aiji Miyashita & Takashi Usui. (2012) Identification of UDP-Glucuronosyltransferases Responsible for the Glucuronidation of Darexaban, an Oral Factor Xa Inhibitor, in Human Liver and Intestine. Drug Metabolism and Disposition 40:2, pages 276-282.
Crossref
Crossref
Alexander V. LyubimovDeepak K. Dalvie & Cho‐Ming Loi. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.
Alexander V. LyubimovJoshua G. DeKeyser & Magang Shou. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
38
.
De-en Han, Yi Zheng, Xijing Chen, Jiake He, Di Zhao, Shuoye Yang, Chunfeng Zhang & Zhonglin Yang. (2012) Identification and Characterization of Human UDP-glucuronosyltransferases Responsible for the In Vitro Glucuronidation of Salvianolic Acid A. Drug Metabolism and Pharmacokinetics 27:6, pages 579-585.
Crossref
Crossref
Nagarajan Sangeetha, Periyaswamy Viswanathan, Thangavel Balasubramanian & Namasivayam Nalini. (2012) Colon cancer chemopreventive efficacy of silibinin through perturbation of xenobiotic metabolizing enzymes in experimental rats. European Journal of Pharmacology 674:2-3, pages 430-438.
Crossref
Crossref
C. J. Kirwan, I. A. M. MacPhee, T. Lee, D. W. Holt & B. J. Philips. (2011) Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients. Intensive Care Medicine 38:1, pages 76-84.
Crossref
Crossref
David S. MillanMark E. BunnageJane L. BurrowsKenneth J. ButcherPeter G. DoddTimothy J. EvansDavid A. FairmanSamantha J. HughesIain C. KiltyArnaud LemaitreRussell A. LewthwaiteAxel MahnkeJohn P. MathiasJames PhilipRobert T. SmithMark H. StefaniakMichael YeadonChristopher Phillips. (2011) Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of Medicinal Chemistry 54:22, pages 7797-7814.
Crossref
Crossref
David S Millan. (2011) What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?. Future Medicinal Chemistry 3:13, pages 1635-1645.
Crossref
Crossref
David S. Millan, Stephen A. Ballard, Sara Chunn, Joseph A. Dybowski, Craig K. Fulton, Paul A. Glossop, Edouard Guillabert, Christopher A. Hewson, Rhys M. Jones, David J. Lamb, Carolyn M. Napier, Toby A. Payne-Cook, Emmanuelle R. Renery, Matthew D. Selby, Michelle F. Tutt & Michael Yeadon. (2011) Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma. Bioorganic & Medicinal Chemistry Letters 21:19, pages 5826-5830.
Crossref
Crossref
Ryan M. Pelis & Stephen H. Wright. 2011. Comprehensive Physiology. Comprehensive Physiology
1795
1835
.
Baojian Wu, Kaustubh Kulkarni, Sumit Basu, Shuxing Zhang & Ming Hu. (2011) First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of Phenolics. Journal of Pharmaceutical Sciences 100:9, pages 3655-3681.
Crossref
Crossref
Rashim Singh & Ming Hu. 2011. Oral Bioavailability. Oral Bioavailability
91
109
.
Stephen Wang. 2011. Oral Bioavailability. Oral Bioavailability
401
412
.
Leslie M. Tompkins & Hongbing Wang. 2011. Oral Bioavailability. Oral Bioavailability
127
144
.
Baojian Wu, Beibei Xu & Ming Hu. (2011) Regioselective Glucuronidation of Flavonols by Six Human UGT1A Isoforms. Pharmaceutical Research 28:8, pages 1905-1918.
Crossref
Crossref
H. Mielke, F. Partosch & U. Gundert-Remy. (2011) The contribution of dermal exposure to the internal exposure of bisphenol A in man. Toxicology Letters 204:2-3, pages 190-198.
Crossref
Crossref
Joana Pinto, Fátima Paiva-Martins, Giulia Corona, Edward S. Debnam, Maria Jose Oruna-Concha, David Vauzour, Michael H. Gordon & Jeremy P. E. Spencer. (2011) Absorption and metabolism of olive oil secoiridoids in the small intestine. British Journal of Nutrition 105:11, pages 1607-1618.
Crossref
Crossref
Shinsuke Uchihashi, Hiroyuki Fukumoto, Makoto Onoda, Hiroyoshi Hayakawa, Shin-ichi Ikushiro & Toshiyuki Sakaki. (2011) Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms. Drug Metabolism and Disposition 39:5, pages 803-813.
Crossref
Crossref
Phillip M. Cowley, James Baker, Kirsteen I. Buchanan, Ian Carlyle, John K. Clark, Thomas R. Clarkson, Maureen Deehan, Darren Edwards, Yasuko Kiyoi, Iain Martin, Dawn Osbourn, Glenn Walker, Nick Ward & Grant Wishart. (2011) Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists. Bioorganic & Medicinal Chemistry Letters 21:7, pages 2034-2039.
Crossref
Crossref
Baojian Wu, John Kenneth Morrow, Rashim Singh, Shuxing Zhang & Ming Hu. (2011) Three-Dimensional Quantitative Structure-Activity Relationship Studies on UGT1A9-Mediated 3-O-Glucuronidation of Natural Flavonols Using a Pharmacophore-Based Comparative Molecular Field Analysis Model. Journal of Pharmacology and Experimental Therapeutics 336:2, pages 403-413.
Crossref
Crossref
Jin Zhou, Timothy S. Tracy & Rory P. Remmel. (2011) Correlation between Bilirubin Glucuronidation and Estradiol-3-Gluronidation in the Presence of Model UDP-Glucuronosyltransferase 1A1 Substrates/Inhibitors. Drug Metabolism and Disposition 39:2, pages 322-329.
Crossref
Crossref
Christopher S. Mazur, John F. Kenneke, Janet K. Hess-Wilson & John C. Lipscomb. (2010) Differences between Human and Rat Intestinal and Hepatic Bisphenol A Glucuronidation and the Influence of Alamethicin on In Vitro Kinetic Measurements. Drug Metabolism and Disposition 38:12, pages 2232-2238.
Crossref
Crossref
L. MATÉ, G. VIRKEL, A. LIFSCHITZ, J. SALLOVITZ, M. BALLENT & C. LANUSSE. (2010) Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep1. Journal of Veterinary Pharmacology and Therapeutics 33:6, pages 537-545.
Crossref
Crossref
Melanie S. Joy, Tammy Boyette, Yichun Hu, Jinzhao Wang, Mary La, Susan L. Hogan, Paul W. Stewart, Ronald J. Falk, Mary Anne Dooley & Philip C. Smith. (2010) Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis. European Journal of Clinical Pharmacology 66:11, pages 1119-1130.
Crossref
Crossref
Sophie L. Regan, James L. Maggs, Thomas G. Hammond, Craig Lambert, Dominic P. Williams & B. Kevin Park. (2010) Acyl glucuronides: the good, the bad and the ugly. Biopharmaceutics & Drug Disposition 31:7, pages 367-395.
Crossref
Crossref
Paul A. Glossop, Charlotte A. L. Lane, David A. Price, Mark E. Bunnage, Russell A. Lewthwaite, Kim James, Alan D. Brown, Michael Yeadon, Christelle Perros-Huguet, Michael A. Trevethick, Nicholas P. Clarke, Robert Webster, Rhys M. Jones, Jane L. Burrows, Neil Feeder, Stefan C. J. Taylor & Fiona J. Spence. (2010)
Inhalation by Design: Novel Ultra-Long-Acting β
2
-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup
. Journal of Medicinal Chemistry 53:18, pages 6640-6652.
Crossref
Crossref
Thomas Ebner, Klaus Wagner & Wolfgang Wienen. (2010) Dabigatran Acylglucuronide, the Major Human Metabolite of Dabigatran: In Vitro Formation, Stability, and Pharmacological Activity. Drug Metabolism and Disposition 38:9, pages 1567-1575.
Crossref
Crossref
Jeremiah D. Momper, Raman Venkataramanan & Thomas D. Nolin. (2010) Nonrenal Drug Clearance in CKD: Searching for the Path Less Traveled. Advances in Chronic Kidney Disease 17:5, pages 384-391.
Crossref
Crossref
Nobumitsu Hanioka, Natsuko Tanabe, Hideto Jinno, Toshiko Tanaka-Kagawa, Kenjiro Nagaoka, Shinsaku Naito, Akiko Koeda & Shizuo Narimatsu. (2010) Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes. Life Sciences 87:7-8, pages 261-268.
Crossref
Crossref
Peter L. Bullock. 2010. Early Drug Development. Early Drug Development
89
130
.
Andy ZöllnerDaniela BuchheitMarkus R Meyer, Hans H Maurer, Frank T Peters & Matthias Bureik. (2010) Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes. Bioanalysis 2:7, pages 1277-1290.
Crossref
Crossref
Qiong Wang, Haiping Hao, Xuanxuan Zhu, Guo Yu, Li Lai, Yitong Liu, Yuxin Wang, Shan Jiang & Guangji Wang. (2010) Regioselective Glucuronidation of Tanshinone IIa after Quinone Reduction: Identification of Human UDP-Glucuronosyltransferases, Species Differences, and Interaction Potential. Drug Metabolism and Disposition 38:7, pages 1132-1140.
Crossref
Crossref
Ursula Ehmer, Sandra Kalthoff, Tim O. Lankisch, Nicole Freiberg, Michael P. Manns & Christian P. Strassburg. (2010)
Shared Regulation of
UGT1A7
by Hepatocyte Nuclear Factor (HNF) 1α and HNF4α
. Drug Metabolism and Disposition 38:7, pages 1246-1257.
Crossref
Crossref
Petra Jancova, Pavel Anzenbacher & Eva Anzenbacherova. (2010) PHASE II DRUG METABOLIZING ENZYMES. Biomedical Papers 154:2, pages 103-116.
Crossref
Crossref
Golriz Rad, Simone I. Hoehle, Robert K. Kuester & I. Glenn Sipes. (2010) In Vitro Glucuronidation of 2,2-Bis(bromomethyl)-1,3-propanediol by Microsomes and Hepatocytes from Rats and Humans. Drug Metabolism and Disposition 38:6, pages 957-962.
Crossref
Crossref
Si-Cheng Liang, Guang-Bo Ge, Hui-Xin Liu, Yan-Yan Zhang, Li-Ming Wang, Jiang-Wei Zhang, Lu Yin, Wei Li, Zhong-Ze Fang, Jing-Jing Wu, Guo-Hui Li & Ling Yang. (2010) Identification and Characterization of Human UDP-Glucuronosyltransferases Responsible for the In Vitro Glucuronidation of Daphnetin. Drug Metabolism and Disposition 38:6, pages 973-980.
Crossref
Crossref
G. VIRKEL, M. CARLETTI, M. CANTIELLO, L. DELLA DONNA, G. GARDINI, F. GIROLAMI & C. NEBBIA. (2009) Characterization of xenobiotic metabolizing enzymes in bovine small intestinal mucosa. Journal of Veterinary Pharmacology and Therapeutics 33:3, pages 295-303.
Crossref
Crossref
Sabariah Ismail, Nur Aziah Hanapi, Mohd Rohaimi Ab Halim, Verawan Uchaipichat & Peter Mackenzie. (2010) Effects of Andrographis paniculata and Orthosiphon stamineus Extracts on the Glucuronidation of 4-Methylumbelliferone in Human UGT Isoforms. Molecules 15:5, pages 3578-3592.
Crossref
Crossref
Jacqueline RamírezMark J RatainFederico Innocenti. (2010) Uridine 5´-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy. Future Oncology 6:4, pages 563-585.
Crossref
Crossref
Carl D. Davis & Umesh M. Hanumegowda. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
68
.
Carl D. Davis & A. David Rodrigues. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
58
.
Ruiwen Zhang & Elizabeth R. Rayburn. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
34
.
Juan SU, Yu-Qi HE, Chang-Hong WANG & Zheng-Tao WANG. (2010) Interspecific Difference Assay of UDP-glucuronosyltrans-ferase 1A9 Activities in Liver Microsomes by Ultra-perfor-mance Liquid Chromatography-tandem Mass Spectrometry. Chinese Journal of Natural Medicines 8:1, pages 34-39.
Crossref
Crossref
Arjan Scheepens, Kee Tan & James W. Paxton. (2009) Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes & Nutrition 5:1, pages 75-87.
Crossref
Crossref
Sepuri Asha & Maravajhala Vidyavathi. (2009) Role of Human Liver Microsomes in In Vitro Metabolism of Drugs—A Review. Applied Biochemistry and Biotechnology 160:6, pages 1699-1722.
Crossref
Crossref
M. Teresa Donato, Sandra Montero, José V. Castell, M. José Gómez-Lechón & Agustín Lahoz. (2010) Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies. Analytical and Bioanalytical Chemistry 396:6, pages 2251-2263.
Crossref
Crossref
Olga Trubetskoy, Moshe Finel & Vladimir Trubetskoy. (2008) High-throughput screening technologies for drug glucuronidation profiling. Journal of Pharmacy and Pharmacology 60:8, pages 1061-1067.
Crossref
Crossref
Barbora Szotáková, Lenka Skálová, Petr Jílek, Vladimír Buchta & Vladimír Wsól. (2003) Stereospecific reduction of the original anticancer drug oracin in rat extrahepatic tissues. Journal of Pharmacy and Pharmacology 55:7, pages 1003-1011.
Crossref
Crossref
Aleksandra Galetin, Michael Gertz & J. Brian Houston. (2010) Contribution of Intestinal Cytochrome P450-Mediated Metabolism to Drug-Drug Inhibition and Induction Interactions. Drug Metabolism and Pharmacokinetics 25:1, pages 28-47.
Crossref
Crossref
Juan SU, Yu-Qi HE, Chang-Hong WANG & Zheng-Tao WANG. (2010) Interspecific Difference Assay of UDP-glucuronosyltransferase 1A9 Activities in Liver Microsomes by Ultra-performance Liquid Chromatography-tandem Mass Spectrometry. Chinese Journal of Natural Medicines 8:1, pages 34-39.
Crossref
Crossref
K.K. Wolf, M.F. Paine & P.B. Watkins. 2010. Comprehensive Toxicology. Comprehensive Toxicology
53
75
.
Ryoichi Fujiwara, Miki Nakajima, Shingo Oda, Hiroyuki Yamanaka, Shin-ichi Ikushiro, Toshiyuki Sakaki & Tsuyoshi Yokoi. (2010) Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. Journal of Pharmaceutical Sciences 99:1, pages 442-454.
Crossref
Crossref
Hans Mielke & Ursula Gundert-Remy. (2009) Bisphenol A levels in blood depend on age and exposure. Toxicology Letters 190:1, pages 32-40.
Crossref
Crossref
Stefanie D. Krämer & Bernard Testa. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:10, pages 1477-1660.
Crossref
Crossref
Takeshi Izukawa, Miki Nakajima, Ryoichi Fujiwara, Hiroyuki Yamanaka, Tatsuki Fukami, Masataka Takamiya, Yasuhiro Aoki, Shin-ichi Ikushiro, Toshiyuki Sakaki & Tsuyoshi Yokoi. (2009) Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers. Drug Metabolism and Disposition 37:8, pages 1759-1768.
Crossref
Crossref
Masato Chiba, Yasuyuki Ishii & Yuichi Sugiyama. (2009) Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development. The AAPS Journal 11:2.
Crossref
Crossref
Shane J Cross, John H Rodman, Jane C Lindsey, Brian L Robbins, Charles H Rose, Geoffrey J Yuen & Lawrence J D'Angelo. (2009) Abacavir and Metabolite Pharmacokinetics in HIV-1-Infected Children and Adolescents. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:1, pages 54-59.
Crossref
Crossref
Displaying 200 of 307 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list